These antibodies can have a direct impact on muscle tissues that express HMGCR, leading to symptoms such as myalgia, myopathy, myonecrosis, and significant muscle fiber necrosis, as evidenced by muscle biopsy results (Brunham et al., 2018). Here, HMGCR is linked to Myalgia.